Dendritic cell preparation for immunotherapeutic interventions

Interferon-alpha (IFN-α)–conditioned DC Preferentially Stimulate Type-1 and Limit Treg-type In Vitro T-cell Responses From RCC Patients

(2009) Margherita Gigante et al.   JOURNAL OF IMMUNOTHERAPY

Dendritic cell vaccines in acute leukaemia

(2008) Caroline Duncan et al.   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY

Development of a dendritic cell-based vaccine for chronic lymphocytic leukemia

(2008) M. Palma et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Maturation of monocyte-derived dendritic cells with Toll-like receptor 3 and 7/8 ligands combined with prostaglandin E2 results in high interleukin-12 production and cell migration

(2008) A. C. Inge Boullart et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Dendritic cell vaccination and immune monitoring

(2008) E. H. J. G. Aarntzen et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Molecular Interactions between Dying Tumor Cells and the Innate Immune System Determine the Efficacy of Conventional Anticancer Therapies

(2008) L. Apetoh et al.   CANCER RESEARCH

Survivin: Key Regulator of Mitosis and Apoptosis and Novel Target for Cancer Therapeutics

(2008) A. C. Mita et al.   CLINICAL CANCER RESEARCH

Immune cells in colorectal cancer: prognostic relevance and therapeutic strategies

(2008) Imke Atreya et al.   Expert Review of Anticancer Therapy

Human Effector and Memory CD8+ T Cell Responses to Smallpox and Yellow Fever Vaccines

(2008) Joseph D. Miller et al.   IMMUNITY

Combined use of toll-like receptor agonists and prostaglandin E2 in the FastDC model: Rapid generation of human monocyte-derived dendritic cells capable of migration and IL-12p70 production

(2008) Marc Dauer et al.   JOURNAL OF IMMUNOLOGICAL METHODS

Type 1-polarized dendritic cells loaded with autologous tumor are a potent immunogen against chronic lymphocytic leukemia

(2008) Je-Jung Lee et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Natural killer cell–directed therapies: moving from unexpected results to successful strategies

(2008) Magali Terme et al.   NATURE IMMUNOLOGY

Treatment of Metastatic Melanoma with Autologous CD4+ T Cells against NY-ESO-1

(2008) Naomi N. Hunder et al.   NEW ENGLAND JOURNAL OF MEDICINE